A Study of LY2624587 in Patients With Advanced Cancer
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | June 2010 |
| End Date: | January 2012 |
A Phase 1 Study of LY2624587 in Patients With Advanced Cancer
Study CXBA is a multicenter nonrandomized, dose escalation, open-label, Phase 1 study of
intravenous LY2624587 in patients with advanced or metastatic cancer for which no treatment
of higher priority exists.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials